Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J AOAC Int ; 100(6): 1747-1753, 2017 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-28776492

RESUMO

This study presents the development and validation of UV spectrophotometric methods for the determination of pinaverium bromide (PB) in tablet assay and dissolution studies. The methods were satisfactorily validated according to International Conference on Harmonization guidelines. The response was linear (r2 > 0.99) in the concentration ranges of 2-14 µg/mL at 213 nm and 10-70 µg/mL at 243 nm. The LOD and LOQ were 0.39 and 1.31 µg/mL, respectively, at 213 nm. For the 243 nm method, the LOD and LOQ were 2.93 and 9.77 µg/mL, respectively. Precision was evaluated by RSD, and the obtained results were lower than 2%. Adequate accuracy was also obtained. The methods proved to be robust using a full factorial design evaluation. For PB dissolution studies, the best conditions were achieved using a United States Pharmacopeia Dissolution Apparatus 2 (paddle) at 50 rpm and with 900 mL 0.1 M hydrochloric acid as the dissolution medium, presenting satisfactory results during the validation tests. In addition, the kinetic parameters of drug release were investigated using model-dependent methods, and the dissolution profiles were best described by the first-order model. Therefore, the proposed methods were successfully applied for the assay and dissolution analysis of PB in commercial tablets.


Assuntos
Morfolinas/análise , Morfolinas/química , Espectrofotometria Ultravioleta/métodos , Liberação Controlada de Fármacos , Limite de Detecção , Morfolinas/farmacocinética , Solubilidade , Comprimidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA